Precise Identification and Safety Qualification for Pharmaceutical Excellence
At Indivirtus Healthcare Services Pvt. Ltd., our expert Impurity Profiling services deliver unparalleled precision in identifying, characterizing, and qualifying pharmaceutical impurities. Using advanced analytical techniques including LC-MS/MS, GC-MS, NMR, and HRMS, we ensure complete regulatory compliance with ICH Q3A/B and M7 guidelines, empowering your global market success.
We deliver comprehensive impurity identification, characterization, and toxicological qualification using cutting-edge analytical technology and expert TTC evaluations, ensuring seamless compliance with international standards and regulatory confidence.
Professional impurity profiling guarantees pharmaceutical safety and quality, streamlines regulatory approvals, and eliminates compliance risks by accurately identifying and qualifying even the most challenging trace-level impurities.
As your dedicated CRO partner, Indivirtus Healthcare Services provides world-class impurity profiling expertise, delivering precise, regulator-approved data that accelerates your path to global market authorization.
At Indivirtus Healthcare Services, our Impurity Profiling services are powered by certified analytical and toxicology specialists with extensive global regulatory experience. We employ the most advanced analytical instruments, including LC-MS/MS, GC-MS, high-field NMR, and HRMS, to achieve unmatched precision in impurity identification and structural characterization.
Our comprehensive methodology encompasses advanced toxicological qualification and detailed TTC evaluations, ensuring submission-ready reports that fully align with ICH Q3A/B, ICH M7, EMA, and FDA guidelines. This approach guarantees pharmaceutical safety while supporting successful regulatory submissions worldwide.
Comprehensive Analytical Characterization Report: In-depth impurity identification with detailed analytical methodology and results.
Complete Structure Elucidation Package: Comprehensive MS/NMR structural data with expert interpretation and confirmation.
Professional TTC Evaluation Report: Thorough Threshold of Toxicological Concern assessment when required for regulatory compliance.
Regulatory-Grade Impurity Qualification Summary: Complete qualification documentation meeting international regulatory standards.
Our Impurity Profiling services exceed the most stringent international regulatory standards, ensuring your submissions achieve immediate regulatory acceptance and demonstrate unwavering commitment to patient safety. Through meticulous adherence to industry-leading guidelines, we deliver solutions that build regulatory confidence and enhance product integrity.
Our Impurity Profiling services are indispensable for pharmaceutical companies committed to ensuring exceptional product safety and achieving regulatory excellence. Perfect for both drug substance and product development phases, our solutions accelerate global regulatory approvals. Key applications include comprehensive impurity analysis for innovative drug formulations, expert qualification support for NDA submissions, and specialized TTC evaluations for complex regulatory filings.
Indivirtus Healthcare Services stands as the preferred partner for leading pharmaceutical companies, delivering unmatched impurity profiling expertise supported by certified analytical and toxicology professionals with proven global experience. Our services guarantee scientifically robust outcomes, accelerated project timelines, and absolute confidentiality to safeguard your valuable intellectual property.
With an unwavering commitment to scientific excellence and industry best practices, we empower your organization with compliant, comprehensive impurity data that drives regulatory success and ensures patient safety across global markets.
Pharmaceutical impurity profiling is the comprehensive process of detecting, identifying, and evaluating chemical impurities present in drug substances or finished pharmaceutical products. This critical process ensures patient safety and regulatory compliance with established guidelines such as ICH Q3A/B and M7.
We employ state-of-the-art analytical instruments including LC-MS/MS, GC-MS, high-field NMR spectroscopy, and High-Resolution Mass Spectrometry (HRMS) to accurately identify and characterize even the most challenging trace-level pharmaceutical impurities.
TTC is a scientifically validated risk assessment approach that establishes safe exposure levels for pharmaceutical impurities when comprehensive toxicological data is limited. This method enables informed regulatory decision-making and supports efficient drug development processes.
Impurity qualification becomes mandatory when impurities exceed the identification or qualification thresholds specified in ICH Q3A/B or M7 guidelines. This process demonstrates that identified impurities pose no significant toxicological risk to patients.
Absolutely. Our comprehensive impurity profiling services are conducted in complete alignment with ICH Q3A/B and M7 guidelines, utilizing fully validated analytical methods and producing regulatory-grade documentation that meets international standards.
Our complete service package includes advanced impurity identification, detailed characterization, comprehensive structure elucidation, professional TTC evaluations, and thorough qualification summaries using cutting-edge analytical techniques and expert interpretation.
Pharmaceutical companies developing drug substances or finished products, biotechnology firms preparing regulatory submissions, and organizations requiring comprehensive impurity analysis for global market approval benefit significantly from our specialized profiling solutions.
Our services maintain strict alignment with ICH Q3A/B, ICH M7, EMA, and FDA impurity guidelines through validated methodologies, expert review processes, and comprehensive documentation that ensures seamless global regulatory compliance.
You will receive comprehensive analytical characterization reports, detailed structure elucidation data with expert interpretation, professional TTC evaluation reports when applicable, and complete impurity qualification summaries ready for regulatory submission.
Yes, our services are fully customizable to address your specific drug substances, pharmaceutical products, and unique regulatory requirements, ensuring tailored solutions that meet your exact compliance and business needs.
We provide submission-ready reports and comprehensive qualification summaries that meet regulatory expectations, supporting impurity data requirements for NDA, ANDA, and other global regulatory submissions with confidence and efficiency.